CRI Home | Instiutional Review Board | Current Studies | Major Grant Awards | Behavioral Pathway Systems
Changes in Heart Rhythms (QTC intervals) Associated With Antipsychotic Drug Treatment
Y The National Suicide Prevention Lifeline Network (Follow-Up)
Y Orally Disintegrating Versus Regular Olanzapine (Zyprexa) Tablets: Effects on Weight and Gastro-Intestinal Hormones (Richard Shelton, MD)
A Comparison of Clozapine (Clozaril) and Quetiapine (Seroquel) and How They Work in the Brain (NIMH) (Herbert Meltzer & Robert Kessler)
A 25-Year Evaluation of the Efficacy of RIP (Regional Intervention Program) (Phil Strain & Matthew Timm)
Assisting Older Adults with Mental Illness: A Study of the Effectiveness of an Inter-disciplinary Mental Health Team (Sherry M. Cummings)
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors (Herbert Y. Meltzer & Myung Lee)
TAMHO Crisis Mobile Survey (Brian Jones)
Vanderbilt Fast Track Project (Ellen Pinderhughes & Alison Fuller)
Comparison of Effectiveness (CATIE) (Herbert Y. Meltzer)
Olanzapine Versus Clozapine in Treatment of Refractory Schizophrenia (Lilly) (Herbert Y. Meltzer)
Communication Interventions with Parents, Teachers and Physicians of Children with ADHD (Mark L. Wolraich)
The Effects of Stigma: Looking at Discrimination Among People with Mental Illnesses (Patrick W. Corrigan)
Sequenced Treatment Alternatives to Relieve Depression (Star*D/Adult) (Steven Hollon & Richard C. Shelton)
Infants’ Learning in Response to Speech from Depressed and Non-Depressed Mothers (Moria Smoski)
Serotonin 1A Agonists and Cognition in Schizophrenia (Herbert Y. Meltzer)
A 12-week Multicentered, Randomized, Double-Blind Placebo-Controlled Evaluation of Donepezil Hydrochloride (Herbert Y. Meltzer)
A Randomized, Double-Blind, Placebo-Controlled Risperidone Referenced Dose-Finding Study of DU127090 in Treatment of Schizophrenia (Herbert Y. Meltzer)
Students with Emotional and Behavioral Disorders and the Transition from School to Work (Becky Henderson)
Children of Mothers with Depression: A Look at the Effects of Treatment and Remission (Judy Garber)
NIMH Human Genetics Initiative (Steven Hollon)
Frequency of Psychological Diagnoses in Relationship to Inpatient Psychiatric Hospitalization (Dissertation) (Shannon Davis)
Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-Treated Patients with Schizophrenia (NARSAD) (Herbert Y. Meltzer)
Caregivers of Older Clients with Severe Mental Illness: A Look at Perception of Burdens & Rewards (Sherry M. Cummings)
A Group Cognitive Behavioral Program for Preventing Depression in At-Risk Adolescents (Judy Garber)
Attention and Verbal Memory: A Look at the Effects of Acute Nicotine Abstinence (David W. Ayer)
A Study of the Effect of Lamotrigine (Lamictal) on Patients with Schizophrenia (Herbert Y. Meltzer)
Service Needs and Perceptions of Service Adequacy of Older Persons with Severe Mental Illness (Sherry M. Cummings)
Looking at the Efficacy and Safety of Extended Release Paliperidone (INVEGA) for Schizophrenia: A 6-week Randomized Control Trial and a 52-week Open-Label Extension (Herbert Y. Meltzer)
Possible Adverse Effect of Psychotropics on Metabolic Status (Herbert Y. Meltzer)
Assessment Measures and Behavior Performance (Qusayy M. Godbolt)
Homeless Adult Program-Research Program (CHAP-RP) (Thomas W. Doub & Olivia Evans)
MR Studies of Alcohol-Induced Brain Injury and Recovery (Peter R. Martin)
A Study Comparing Ageism and General Knowledge about the Elderly in Mental Health Professionals (Christi DeBlanc)
A Multicenter, Randomized, Double-Blind, Fixed-Dose, 6-week Trial of the Efficacy and Safety of Asenapine Compared with Placebo Using Haloperidol Positive Control in Subjects with an Acute Exacerbation of Schizophrenia (Organon/Pfizer Clinical Trial Protocol 041023) (Herbert Y. Meltzer)
A Multicenter, Randomized, Double-Blind, flexible-Dose, Long-Term Extension Trial of Protocol 041023 (Herbert Y. Meltzer)
Evaluation of Adherence to Monitoring Options for Patients’ Receiving Atypical Antipsychotics (Elizabeth Swope)
A Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind, Phase III Study to compare the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) versus Placebo as Adjunct Therapy with Mood Stabilizers (Lithium or Divalproex) for the Treatment of Alcohol Dependence in Patients with Bipolar I Disorder (Tianlai Tang)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Response, Multicenter Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-Release Paliperidone (3, 6, and 12 mg/day) in the Treatment of Subjects With Acute Manic and Mixed Episodes Associated With Bipolar I Disorder (Herbert Y. Meltzer)
An Open-Label Extension to R076477-SCH-304 Study (A Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of 2 Fixed Dosages of Extended Release OROS® Paliperidone (6 and 12 mg/day) and Olanzapine (10 mg/day), with Open-Label Extension, in the Treatment of Subjects with Schizophrenia (J & J R076477-SCH-704) (Herbert Y. Meltzer)
A Multicenter, Randomized, Double-blind study on the Effects of Aripiprazole on Overweight Patients Treated with Olanzapine for Schizophrenia or Schizoaffective Disorder (Bristol-Myers Squibb protocol CN138122) (Herbert Y. Meltzer)
Patient Characteristics and Outcomes in a Partial Hospitalization Program at a Community Mental Health Center (Rhonda Thompson)
An International, Multicentered, Large Simple Trial (LST) to compare the Cardiovascular Safety of Ziprasidone and Olanzapine (Pfizer A1281062) (Herbert Y. Meltzer)
A multicenter, randomized, double-blind, flexible dose, long-term extension trial of the safety and maintenance of effect of asenapine using haloperidol positive control in subjects who complete protocol 041023 (Organon/Pfizer Clinical Trial Protocol 041513) (Herbert Y. Meltzer)
A Multicenter, Randomized, Double-Blind Placebo-Controlled, 16-Week Study of Aripiprazole Used as Dual Therapy in the Treatment of Patients with Chronic Stable Schizophrenia or Schizoaffective Disorder Demonstrating an Inadequate Response to Quetiapine or Risperidone Monotherapy (Bristol-Myers Squibb Protocol CN138397) (Herbert Y. Meltzer)
Differentiating Risperidone and Paliperidone with Measures of Metabolites in Anterior Cingulate Cortex and Thalamus Using Proton Magnetic Resonance Spectroscopy in Patients With Schizophrenia (Herbert Y. Meltzer)
Improving Service Provision and Retention in the Mule Town Family Network (Craig Anne Heflinger)
The National Suicide Prevention Lifeline Network (Silent Monitoring) (John Kalafat)